Molecular Pathology Will Lean Further into Liquid Biopsy and Proteomics in 2026
Scott Wallask, BA, Luca Quagliata, PhD, BCMAS, COA
Thermo Fisher’s Luca Quagliata also discusses pathologists’ desire for rapid turnaround times
Thermo Fisher’s Luca Quagliata also discusses pathologists’ desire for rapid turnaround times